Nothing is identical, comparison is just a quick snapshot of illustrating the valuation gap between the two.
Acadia involvement has pros and cons, obviously eroding some profit but taking risk off. NEU is just picking ~US$1b prepayments and milestone payments, plus 10-20s% royalties on every dollar net sales globally, that’s virtually no costs required, all these payments and royalties go straight towards profit. So you make adjustments accordingly.
Also as you are aware 2591 could be bigger than DAYBUE.
All imo.
- Forums
- ASX - By Stock
- NEU
- NEU Vs Reata
NEU
neuren pharmaceuticals limited
Add to My Watchlist
6.69%
!
$14.20

NEU Vs Reata, page-30
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.20 |
Change
0.890(6.69%) |
Mkt cap ! $1.761B |
Open | High | Low | Value | Volume |
$13.50 | $14.26 | $12.96 | $9.111M | 655.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | $14.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.23 | 3278 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1300 | 14.030 |
1 | 500 | 14.000 |
1 | 357 | 13.970 |
1 | 30 | 13.900 |
1 | 700 | 13.700 |
Price($) | Vol. | No. |
---|---|---|
14.260 | 2920 | 1 |
14.300 | 1000 | 1 |
14.380 | 72 | 1 |
14.400 | 1000 | 1 |
14.460 | 434 | 1 |
Last trade - 16.15pm 27/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online